Estimation of Serum Minerals, Total Protein and Liver Enzymes in HIV Patients Receiving Haart in Federal Medical Centre, Keffi, Nasarawa State, Nigeria

Idowu Abigail Gbolahan *

Department of Medical Laboratory Science, College of Health Sciences, Igbinedion University Okada, Edo State, Nigeria.

Mokwenye Victoria

Department of Medical Laboratory Science, College of Health Sciences, Igbinedion University Okada, Edo State, Nigeria.

Daniel Ohilebo Ugbomoiko

Department of Medical Laboratory Science, College of Health Sciences, Igbinedion University Okada, Edo State, Nigeria.

Ezekiel Dauda Gambo

Department of Medical Laboratory Science, College of Health Sciences, Igbinedion University Okada, Edo State, Nigeria.

Muhammad Adamu Ibrahim

Department of Immunology, School of Medical Laboratory Science, Usmanu Danfodiyo University, Sokoto State, Nigeria.

*Author to whom correspondence should be addressed.


Aims: This study was aimed to estimate serum minerals level (calcium, zinc, phosphorus), total protein and liver enzymes (ALT and AST) in patients taking HAART at Federal Medical Centre Keffi, Nasarawa state. Nigeria.

Study design: This study engaged a cross-sectional study design to investigate the liver enzyme alterations and the level of serum minerals in patients taking HAART when compare with treatment naïve (Pre-HAART) controls.

Place and duration of the study: The study was conducted in Federal Medical Center Keffi, Nasarawa State-Nigeria. Data collection spanned a specific duration from December, 2022 to March, 2023.

Method: A total of 143 subjects were involved in the study of which were 59 HIV positive patients on HAART, 34 Pre-HAART patients and 50 healthy subjects served as controls. 5ml venous blood sample was collected after taking aseptic precaution from the study subjects into plain vacuum tubes; sample was left for 30 minutes at room temperature and centrifuged at 3000 rpm for 4 minutes. Sero-negativity of the control (healthy patients) was confirmed by HIV TRI-DOT test. Serum total calcium, serum phosphorus, serum zinc. Total proteins were estimated using spectrophotometer while AST and ALT were estimated by colorimetric method.

Result: The study indicated that both pre-HAART and HAART patients showed significantly higher (P<.05) AST and ALT activities compared to sero-negative patients. Pre-HAART patients had lower Zinc (11.22±4.86) and TP (43.18±22.52) levels than sero-negative patients, with Zinc (16.58±4.20) and TP (65.47±12.79). In contrast, HAART patients experienced a significant increase (P<.005) in Zinc (14.29±3.41) and TP (61.56±18.87) levels compared to pre-HAART patients (11.22±4.86) and (43.18±2.52). No significant difference in serum calcium level in all groups. Patients on HAART and sero-negative patients displayed normal Phosphorus level which is significantly higher in pre-HAART patients.

Conclusion: This study concluded that the serum level of ALT and AST were increased in HIV positive patients on HAART and pre-HAART patients. HAART improved level of serum zinc and total protein.

Keywords: Antiretroviral therapy, serum minerals, serum protein, liver enzymes

How to Cite

Gbolahan , I. A., Victoria , M., Ugbomoiko, D. O., Gambo , E. D., & Ibrahim , M. A. (2023). Estimation of Serum Minerals, Total Protein and Liver Enzymes in HIV Patients Receiving Haart in Federal Medical Centre, Keffi, Nasarawa State, Nigeria. Asian Journal of Research in Biochemistry, 13(3), 1–11.


Download data is not yet available.


Zhang YZ, Li HJ, Cheng JL, Wu H, Bao DY. Computed tomographic demonstrations of HIV seropositive pulmonary tuberculosis and their relationship with CD4+ T-lymphocyte count. Chin Med J (Engl). 2011;124(5):693-698.

Kaplowitz N. Drug-induced liver disorders: Implications for drug development and regulation. Drug Saf. 2001;24(7):483-490.


Fokunang C, Banin A, Kouanfack C, Ngogang J. Evaluation of hepatotoxicity and nephrotoxicity in HIV patients on highly active anti-retroviral therapy. J. of AIDS HIV Res. 2010;2(3):048–57.

Marc G, Jay HH, Fauci S, Braunwald E, Kasper L, Hauser L, Longo L, Jameson L, Loscalzo JH. Principles of internal medicine. 17th ed. New York: McGraw-Hill Companies; 2008;1918–2000.

Khan K, Khan A, Sulaiman S, Soo C,Aftab R. Adverse effect of highly active anti-retroviral therapy (HAART) in HIV/AIDS patients. Indian J. of Pharm. Pract; 2014.

Available: https :// .7.3.7.

Savita M, Singh B, Vengadakrishnan K, Damodharan J. Liver function abnormalities in human immunodeficiency virus positive individuals and its correlation with disease severity. International Journal of Science Study. 2015;3(8):15–8.

Available: https :// /ijss/2015/499.

Akinboro AO, Onayemi O, Ayodele OE, Mejiuni AD, Atiba AS. The impacts of first line highly active antiretroviral therapy on serum selenium, CD4 count and body mass index: A cross-sectional and short prospective study. Pan African Medical Journal. 2013;15:97.

Akinola FF, Akinjinmi AA, Oguntibeju OO. Effect of Combined Antiretroviral Therapy on Selected Trace Elements and CD4 T-cell Count in HIV-Positive Persons in an African Setting. Journal of AIDS & Clinical Research 2012;3:185.

Berggren R, Batuman V. HIV-associated renal disorders: Recent insights into pathogenesis and treatment. Current HIV/AIDS Rep. 2005;2(3):109–15.

Bobat R, Coovadia H, Stephen C. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: A randomized double-blind placebo-controlled trial. The Lancet 366(9500). 2005;1862-1867.

Burtis CA, Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnosis. 4th ed. Philadelphia: Elsevier Saunders Co; 2006.

Denise M, Tinashe KN, Tawanda JC, Danai TZ. Differences in Serum Levels of Magnesium, Phosphate, and Albumin for HAART-Experienced and HAART-Nave Female Patients Attending Parirenyatwa Opportunistic Infections Clinic in Harare, Zimbabwe. Hindawi Publishing Corporation ISRNAIDS; 2013. ArticleID383214,5pages Available:

Akwa VL, Binbol NL, Marcus ND. Geographical perspective of nasarawa state. Onaivi Printing and Publishing Company Limited, Keffi, Nigeria. 2007;2-3.

Nigeria HIV/AIDS impact and indicator survey (NAIIS, 2019)

Boyvin L, Ak´e J, S´eri K, M’boh G, Yapo A, Djaman J. 25 (OH) vitamin D level and calcium/phosphorus metabolism disorders in patients living with hiv in abidjan. International Journal of Biochemistry Research Review. 2017;17(4):1–7.

Mokwenye VN, Mordi RM. Effect of haart on zinc level in HIV positive women: A prospective cross-sectional study at Tertiary Institution in Midwestern part of Nigeria. Current Approaches in Science and Technology Research. 2021;11:1–8.

Yin MT, Zhang CA, McMahon DJ. Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. Journal of Clinical Endocrinology and Metabolism. 2012;97(2):554–562.

Ugwu MC, Okogun GRA, Okoye CF, Ekebor K L, Nwafia CJ, Nnona AE, Obodo BN. Human serum protein and C- reactive protein level among HIV infected subjects in Uromi and its environs in Edo, Nigeria. International Journal of Basic, Applied and Innovative Research. 2016;5(3).

Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Nino MD, Izquierdo MC, Poveda J. Tenofovir nephrotoxicity:2011update. AIDS Research and Treatment. 2011; 2011. ArticleID354908,11pages,2011

Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemb L, Fielding K. et al. Hepatotoxicity in an African antiretroviral therapy cohort: The effect of tuberculosis and hepatitis B. AIDS. 2007;21(10):1301–8.

Available: https ://doi. org/10.1097/qad.0b013 e3281 4e6b0 8.

Mokwenye VN, Mordi RM, Okoh PNA, Onunu N. Changes in serum transaminases with haart administration in women of reproductive age in Benin, Nigeria. Journal/Nigeria Medical practitioner. 2015;68;4-6.

Available: Article

Udalor GI, Okwuosa CN, Uchendu IK, Agu CE. Effect of Antiretroviral Drugs on Liver Biochemical Parameters of HIV/AIDS-Infected Pregnant Women in Enugu Metropolis, Nigeria: A Cross-Sectional Study. Current Women's Health Reviews. 2021;17(2):156-67.